Madrigal press releases are available below. Search them by keyword or browse by date. Year All20262025202420232022202120202019201820172016 May 7, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) May 6, 2026 Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates May 5, 2026 Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline April 22, 2026 Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026 April 21, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) April 7, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) March 19, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) March 5, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) February 24, 2026 Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference February 19, 2026 Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
May 7, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
May 6, 2026 Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
April 22, 2026 Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
April 21, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
April 7, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
March 19, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
March 5, 2026 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
February 24, 2026 Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
February 19, 2026 Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
